Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
Actual shortage: | 237 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2778 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ELETRIPTAN | 40MG | TABLET | Resolved | 2017-03-10 | 2020-01-07 | 308 |
APO-ENTECAVIR | 0.5MG | TABLET | Resolved | 2017-03-10 | 2017-10-11 | 311 |
APO-EXEMESTANE | 25MG | TABLET | Resolved | 2017-03-10 | 2019-06-12 | 314 |
APO-EZETIMIBE | 10MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 318 |
APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2017-03-10 | 2017-04-10 | 324 |
APO-FUROSEMIDE | 80MG | TABLET | Resolved | 2017-03-10 | 2017-06-05 | 327 |
APO-HYDROCHLOROTHIAZIDE | 100MG | TABLET | Resolved | 2017-03-10 | 2019-11-26 | 330 |
APO-IMIQUIMOD | 5% | CREAM | Resolved | 2017-03-10 | 2019-11-26 | 333 |
APO-IRBESARTAN | 150MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 336 |
APO-IRBESARTAN | 300MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 339 |
APO-IRBESARTAN | 75MG | TABLET | Resolved | 2017-03-10 | 2017-12-14 | 342 |
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 345 |
APO-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-03-10 | 2017-04-24 | 351 |
APO-ISMN | 60MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-10 | 2017-04-10 | 354 |
APO-LATANOPROST | 50MCG | SOLUTION | Resolved | 2017-03-10 | 2020-02-13 | 363 |
APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2017-03-10 | 2017-03-16 | 366 |
APO-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2017-03-10 | 2017-03-16 | 369 |
APO-LORAZEPAM | 0.5MG | TABLET | Resolved | 2017-03-10 | 2017-08-08 | 375 |
APO-MELOXICAM | 15MG | TABLET | Resolved | 2017-03-10 | 2017-07-13 | 378 |
APO-MEMANTINE | 10MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 381 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SUCRALFATE - TAB 1G | 1G | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 61033 |
APO-TADALAFIL | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-02-13 | 61045 |
APO-TAMOX TAB 20MG | 20MG | TABLET | Discontinued | 2018-09-10 | 2019-09-12 | 61050 |
APO-ACETAMINOPHEN | 325MG | TABLET | Discontinued | 2018-10-11 | 2018-10-11 | 63845 |
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64965 |
APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2018-10-25 | 2018-10-25 | 65585 |
APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
APO-CICLESONIDE | 50MCG | SPRAY, METERED DOSE | Discontinued | 2018-12-20 | 2018-12-21 | 70250 |
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70787 |
APO-IBUPROFEN | 300MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70793 |
APO-IBUPROFEN | 400MG | TABLET | Discontinued | 2019-01-02 | 2019-01-02 | 70799 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-07-13 | 70805 |
APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-08-08 | 70807 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2019-01-02 | 2019-01-09 | 70810 |
APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2019-01-02 | 2019-01-02 | 70815 |
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 |